共 10 条
[1]
Leavitt J., Gunning P., Porreca P., Ng S.Y., Lin C.S., Kedes L., Molecular cloning and characterisation of mutant and wild type S-actin alleles, Mol Cell Biol, 4, pp. 1961-1969, (1984)
[2]
Taylor J.J., Haesman P.A., Control genes for reverse transcriptase/polymerase chain reaction (RT-PCR), Brj Haematol, 86, pp. 444-445, (1994)
[3]
Cross N., Lin F., Goldman J.M., Appropriate controls for reverse transcription polymerase chain reaction (RT-PCR), Brj Haematol, 87, (1994)
[4]
Hongjun J., Zhang Q., Leung B.S., Survey of oncogene and growth factor/receptor gene expression in cancer cells by intron-differen-tial RNA/PCR, Biochem Biophys Res Commun, 170, pp. 569-575, (1990)
[5]
Dveksler G.S., Basile A.A., Dieffenbach C.W., Analysis of gene expression: Use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase, PCR Meth Appl, 1, pp. 283-285, (1992)
[6]
Korninger L., Et al., PML-RARa positivity in the bone marrow of patients with APL precedes haematological relapse by 2-3 months, Br J Haematol, 88, pp. 427-431, (1994)
[7]
Lion T., Gaiger A., Henn T., Horth E., Haas O.A., Geissler K., Gadner H., Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon, Leukemia, 9, pp. 1353-1360, (1995)
[8]
Hochhaus A., Et al., Quantification of residual disease in chronic myelogenous leukemia patients on interferon-a therapy by competitive polymerase chain reaction, Blood, 87, pp. 1549-1555, (1996)
[9]
Melo J.V., Kent N.S., Yan S.H., Goldman J.M., Controls for reverse tran-scriptase-polymerase chain reaction amplification of BCR-ABL transcripts, Blood, 84, pp. 3984-3986, (1994)
[10]
Lion T., Prischl F., Haas O.A., Pont J., Schwarzmeier J., Non-radioactive detection of the rearranged BCR/ABL sequences amplified by polymerase chain reaction, Leukemia, 5, pp. 156-159, (1991)